Just reported
From GE HealthCare Technologies's results release of 2026年10月28日; its quarterly report has since been filed.
Actual
US$5.51B
+7.2% y/y
+4.1% q/q
Guided
—
No guide given
Actual
US$1.36
+39% y/y
+9.7% q/q
Guided
—
No guide given
Actual
US$805M
+23% y/y
+8.9% q/q
Guided
—
No guide given
Full year 2026
Set against the company's own guidance and the same quarter a year earlier, not analysts' estimates, which we do not hold. Adjusted figures are the company's own non-GAAP measures, as stated in the release.
The full earnings report →各项收入占比是对nine months ended September 30, 2026的估算,并非来自已提交报告的数字。
Computed tomography scanners
Scanners use X-rays to create cross-sectional and three-dimensional images that can help clinicians find problems such as tumors, blocked blood vessels, or fractures.
Magnetic resonance scanners
Scanners use magnetic fields to create detailed images of internal body structures, including the brain, heart, and muscles.
Ultrasound systems
Systems use sound waves to create images for diagnosis and monitoring, including during pregnancy, heart examinations, and procedures.
X-ray systems
Fixed, portable, and moving-image X-ray equipment helps clinicians examine bones, lungs, and other parts of the body.
Patient monitors and electrocardiogram devices
Devices measure and display signs such as heart rhythm, blood pressure, and oxygen levels so care teams can track patients.
Contrast agents and radiopharmaceuticals
These medicines are given before or during scans to make certain tissues or biological activity easier to see in images.
GE HealthCare makes scanners that create images of the body using X-rays, magnetic fields, or sound waves, along with equipment used to guide procedures and monitor patients. It also sells contrast agents and radioactive imaging drugs that help clinicians interpret scans, and provides equipment maintenance, software, and cloud services. Its software includes tools that use artificial intelligence (AI) to help with image analysis and clinical workflows.
基于 GE HealthCare Technologies Inc. 自己向美国证券交易委员会(SEC)提交的申报文件。数字如实呈报,每股历史已重述到今天的股数口径。 这是对一门生意的描述——不是投资建议,也不是买卖任何证券的推荐。
The themes GE HealthCare Technologies is part of, the highest-graded companies in its industry, and the companies in its sector whose grade rose recently.
Graded A or B and worth $2B or more: A first, then the largest.
Rose to A or B on a filing in the last 90 days, worth $2B or more: largest first.
US$83.05+1.5%11月13日 收盘
数据截至2026年9月30日,来自2026年10月28日提交的10-Q
GE HealthCare sells medical imaging scanners and ultrasound systems to hospitals and health systems, plus diagnostic imaging drugs.
Grade A
价格下方的色带显示每个日期的评级,仅依据当时已公开的文件计算。
显示 GE HealthCare Technologies Inc. 评级历史 11 个季度中的 2 个。 其余 9 个可回溯到 2024年2月。